Science News
from research organizations

Not by DNA alone: How the epigenetics revolution is fostering new medicines

Date:
April 18, 2012
Source:
American Chemical Society
Summary:
Scientific insights that expand on the teachings of Mendel, Watson and Crick, and underpinnings of the Human Genome Project are moving drug companies along the path to development of new medicines based on deeper insights into how factors other than the genetic code influence health and disease. That's the topic of the cover story in Chemical & Engineering News, the weekly news magazine of the American Chemical Society, the world's largest scientific society.
Share:
FULL STORY


Story Source:

Materials provided by American Chemical Society. Note: Content may be edited for style and length.


Cite This Page:

American Chemical Society. "Not by DNA alone: How the epigenetics revolution is fostering new medicines." ScienceDaily. ScienceDaily, 18 April 2012. <www.sciencedaily.com/releases/2012/04/120418135302.htm>.
American Chemical Society. (2012, April 18). Not by DNA alone: How the epigenetics revolution is fostering new medicines. ScienceDaily. Retrieved May 23, 2017 from www.sciencedaily.com/releases/2012/04/120418135302.htm
American Chemical Society. "Not by DNA alone: How the epigenetics revolution is fostering new medicines." ScienceDaily. www.sciencedaily.com/releases/2012/04/120418135302.htm (accessed May 23, 2017).

RELATED STORIES